Search Results

There are 170408 results for: content related to: Choosing an appropriate control group for an observational study design

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377

  3. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Article first published online : 24 JUN 2015, DOI: 10.1002/pds.3820

  4. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Article first published online : 24 FEB 2014, DOI: 10.1002/pds.3596

  5. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Article first published online : 23 FEB 2012, DOI: 10.1002/pds.3219

  6. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  7. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Article first published online : 27 JAN 2014, DOI: 10.1002/pds.3566

  8. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Article first published online : 13 SEP 2013, DOI: 10.1002/pds.3508

  9. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 560–571, Shibing Yang, Charles B. Eaton, Juan Lu and Kate L. Lapane

    Article first published online : 24 JAN 2014, DOI: 10.1002/pds.3569

  10. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  11. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  12. Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 891–901, Dae Hyun Kim and Sebastian Schneeweiss

    Article first published online : 24 JUN 2014, DOI: 10.1002/pds.3674

  13. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  14. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Article first published online : 18 OCT 2013, DOI: 10.1002/pds.3539

  15. Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 719–727, Ingrid Schubert, Jutta Küpper-Nybelen, Peter Ihle and Petra Thürmann

    Article first published online : 12 APR 2013, DOI: 10.1002/pds.3429

  16. Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1159–1170, Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery

    Article first published online : 25 JUN 2013, DOI: 10.1002/pds.3469

  17. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 435–445, Mir M. Ali, Catherine E. O'Brien, Mario A. Cleves and Bradley C. Martin

    Article first published online : 12 FEB 2015, DOI: 10.1002/pds.3758

  18. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1027–1035, Farshad Kajbaf, Paul Arnouts, Marc de Broe and Jean-Daniel Lalau

    Article first published online : 19 AUG 2013, DOI: 10.1002/pds.3501

  19. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 6, June 2015, Pages: 619–627, Joshua A. Roth, Katharine Bradley, Kenneth E. Thummel, David L. Veenstra and Denise Boudreau

    Article first published online : 8 APR 2015, DOI: 10.1002/pds.3769

  20. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Article first published online : 10 MAR 2014, DOI: 10.1002/pds.3592